California Gov. Gavin Newsom vetoed a bill that would have capped insulin prices at $35 per month, citing his existing plan to make California’s own brand of cheap insulin called CalRx.
In his veto message released Saturday, Newsom said lowering the price of prescription drugs is an ongoing priority for him and that people shouldn’t have to go into debt to pay for life-saving drugs. But he touted the state’s existing partnership with Civica, a nonprofit manufacturer, to create a line of biosimilar insulins costing $30 for a 10mL vial and $55 for five 3mL cartridges, a solution he thinks is more sustainable than capping copays.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.